Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 6/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 3/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 7/20 | 0.44 |
| ▸ | FAAH | O00519 | 4/20 | 0.44 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27971189 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL2759892 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL14611674 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL9430010 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL11303853 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL12676448 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL14155064 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL4649867 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL21806974 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 | |
| SCHEMBL27971187 | 1.00 | CES2 (0.56) | CES2POLBBLMGMNNTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110191781-B | Porous polyurethane polishing pad and preparation method thereof | SKC索密思株式会社 | 2021-05-07 | — | — | CN | claimed |
| US-20250092078-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | DECIDUOUS THERAPEUTICS, INC. (US) | 2025-03-20 | — | — | US | disclosed |
| US-12037357-B2 | Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells | DECIDUOUS THERAPEUTICS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-12037357-B2 | Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells | DECIDUOUS THERAPEUTICS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20240025936-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | DECIDUOUS THERAPEUTICS, INC. (US) | 2024-01-25 | — | — | US | disclosed |
| US-20240025936-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | DECIDUOUS THERAPEUTICS, INC. (US) | 2024-01-25 | — | — | US | disclosed |
| EP-4301374-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | Deciduous Therapeutics, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| CN-117222414-A | Compounds for activating constant natural killer T-cells and methods for eliminating inflammatory senescent cells | 脱落性治疗公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2022187141-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | DECIDUOUS THERAPEUTICS (US) | 2022-09-09 | — | — | WO | disclosed |
| CN-110509623-A | The manufacturing method of laminated body | NITTO DENKO CORP | 2019-11-29 | — | — | CN | disclosed |
| WO-2012091156-A1 | PYRIDAZINONE COMPOUND AND HERBICIDE AND NOXIOUS ARTHROPOD CONTROLLING AGENT COMPRISING IT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-05 | — | — | WO | disclosed |
| US-8092712-B2 | Bent-core LC decorated gold nanoclusters | Ridout & Maybee LLP (CA) | 2012-01-10 | — | — | US | disclosed |
| US-20110062385-A1 | BENT-CORE LC DECORATED GOLD NANOCLUSTERS | UNIVERSITY OF MANITOBA (CA) | 2011-03-17 | — | — | US | disclosed |
| EP-1798250-B1 | Molecules suitable for binding to a metal layer for covalently immobilizing biomolecules | IMEC INTER UNI MICRO ELECTR (BE) | 2008-09-03 | — | — | EP | disclosed |
| CN-1110517-C | Heat-resistant high-nitrile polymer compositions and process for preparing same | MITSUI CHEMICALS INC (JP) | 2003-06-04 | — | — | CN | disclosed |
| CN-1072640-C | Fluorine-contained aromatic compound | ASAHI CHEMICAL IND (JP) | 2001-10-10 | — | — | CN | disclosed |
| CN-1156739-A | Heat-resistant high-nitrile polymer compositions and process for preparing same | MITSUI TOATSU CHEMICALS (JP) | 1997-08-13 | — | — | CN | disclosed |
| CN-1106453-A | Lubricating oil composition containing aromatic compound and refrigeration composition thereof | ASAHI CHEMICAL IND (JP) | 1995-08-09 | — | — | CN | disclosed |
| US-4559153-A | MINERAL OR SYNTHETIC OIL, ALKYLTHIOHYDROCARBYL CARBOXYLIC ACID ANDVEGETABLE OR ANIMAL OIL; COLD ROLLING OF STEEL | PHILLIPS PETROLEUM COMPANY (US) | 1985-12-17 | — | — | US | disclosed |
| EP-0142078-A1 | Metal working lubricant | PHILLIPS PETROLEUM COMPANY (US) | 1985-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110062385-A1 | BENT-CORE LC DECORATED GOLD NANOCLUSTERS | SLC6A13, SLC6A6, LGALS3 | CES2 481/4885POLB 4468/4885BLM 2517/4885 |
| US-12037357-B2 | Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells | IL2, IL4, PBK | CES2 4494/4885POLB 4264/4885BLM 2924/4885 |
| US-20240025936-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | IL2, PBK, IL4 | CES2 4031/4885POLB 3889/4885BLM 2660/4885 |
| US-20250092078-A1 | COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS | IL2, PBK, IL4 | CES2 3996/4885POLB 4221/4885BLM 3042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.